PICO Portalanswers from OpenAlex
Ranibizumab in neovascular age-related macular degeneration
PaperCitations, authors & open-access status
Ranibizumab in neovascular age-related macular degeneration is a paper indexed in PICO Portal from OpenAlex.
How many citations does Ranibizumab in neovascular age-related macular degeneration have?
PICO Portalcitation count
Ranibizumab in neovascular age-related macular degeneration has 223 citations in the OpenAlex counts PICO Portal stores.
When was Ranibizumab in neovascular age-related macular degeneration published?
PICO Portalyear
Ranibizumab in neovascular age-related macular degeneration has 2006 year in the PICO Portal index.
What is the open-access status of Ranibizumab in neovascular age-related macular degeneration?
PICO Portaloa status
Ranibizumab in neovascular age-related macular degeneration has gold oa status in the PICO Portal index.
What is the DOI of Ranibizumab in neovascular age-related macular degeneration?
PICO Portaldoi
The DOI for Ranibizumab in neovascular age-related macular degeneration is on the source record.
What is the PMID of Ranibizumab in neovascular age-related macular degeneration?
PICO Portalpmid
The PMID for Ranibizumab in neovascular age-related macular degeneration is on the source record.
What is the OpenAlex record for Ranibizumab in neovascular age-related macular degeneration?
PICO Portalopenalex
The OpenAlex for Ranibizumab in neovascular age-related macular degeneration is on the source record.